Home Cart Sign in  
Q13253-Human Noggin-3d structure.jpg Q13253-Human Noggin-3d structure.jpg

Human Noggin+Cell Based Assay.jpg Human Noggin+Cell Based Assay.jpg In the presence of BMP-4, inhibits alkaline phosphatase production in ATDC5 cells. ED50: 10-100 ng/mL (QC verified).

In the presence of BMP-4, inhibits alkaline phosphatase production in ATDC5 cells. ED50: 10-100 ng/mL (QC verified).

Human Noggin+SDS-PAGE.jpg Human Noggin+SDS-PAGE.jpg Greater than 95% as determined by reducing SDS-PAGE.

Greater than 95% as determined by reducing SDS-PAGE.

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Recombinant Human Noggin is a human-derived, untagged protein expressed in human cells. As an antagonist of bone morphogenetic proteins (BMPs), it is a secreted homodimeric glycoprotein. The mature form contains an N-terminal acidic region, a central basic heparin-binding domain, and a C-terminal cysteine knot structure. It shares high homology with Noggin proteins from various vertebrates, can bind heparin-associated proteoglycans, and functions by blocking BMP binding to their receptors. This protein is involved in stem cell culture and neural development regulation.

Synonyms: Recombinant Human Noggin; Noggin; NOG

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Human Noggin

M.W : 23 KDa
SMILES Code : NONE
Synonyms :
Recombinant Human Noggin; Noggin; NOG

Safety of Human Noggin

Isoform Comparison

Biological Activity

Description
Noggin is a secreted homodimeric glycoprotein that is an antagonist of bone morphogenetic proteins (BMPs). Mature Human Noggin contains an N-terminal acidic region, a central basic heparin-binding segment and a C-terminal cysteine-knot structure. Noggin is very highly conserved among vertebrates, such that mature human Noggin shares 99%, 99%, 98%, 97% and 89% aa sequence identity with mouse, rat bovine, equine and chicken Noggin, respectively. Secreted Noggin probably remains close to the cell surface due to its binding of heparin-containing proteoglycans. Noggin binds some BMPs such as BMP4 with high affinity and others such as BMP7 with lower affinity. It antagonizes BMP bioactivities by blocking epitopes on BMPs that are needed for binding to both type I and type II receptors. Noggin is expressed in defined areas of the adult central nervous system and peripheral tissues such as lung, skeletal muscle and skin. During culture of human embryonic stem cells (hESC) or neural stem cells under certain conditions, addition of Noggin to antagonize BMP activity may allow stem cells to proliferate while maintaining their undifferentiated state, or alternatively, to differentiate into dopaminergic neurons.
Protein Species Human
Expression System Human Cells
Tag Tag free
Protein Expression Interval Gln28-Cys232
Protein ID Q13253
Endotoxin < 0.01 EU/µg as determined by LAL test.
Characteristics Lyophilized powder
Formulation Description Lyophilized from a 0.2 μm filtered solution of 20mM PB, 500mM NaCl, 2mM EDTA, pH 7.4.
Reconstitution Method Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
For long-term storage, it is recommended to dilute the product further with a solution containing carrier proteins (e.g., 0.1% BSA, 10% FBS, or 5% HSA). For serum-free cultures or in vivo animal experiments where BSA, FBS, or HSA cannot be present in the cytokine preparation, trehalose may be used as an alternative carrier. Aliquots should be stored frozen at -20°C to -80°C.
Note: Low-adsorption tubes are recommended for aliquot storage, and repeated freeze-thaw cycles should be avoided. The dilution concentration for aliquoting should not be lower than 10 μg/mL, and the aliquot volume should be no less than 10 μL.
Aliquoted protein remains stable for up to 3 months when stored at ≤ -20°C.
 

Historical Records

Categories